EMRO Balance Sheet Health
Financial Health criteria checks 4/6
EMRO has a total shareholder equity of ₩28.9B and total debt of ₩14.9B, which brings its debt-to-equity ratio to 51.7%. Its total assets and total liabilities are ₩91.6B and ₩62.7B respectively. EMRO's EBIT is ₩4.7B making its interest coverage ratio 4.2. It has cash and short-term investments of ₩11.1B.
Key information
51.7%
Debt to equity ratio
₩14.92b
Debt
| Interest coverage ratio | 4.2x |
| Cash | ₩11.14b |
| Equity | ₩28.86b |
| Total liabilities | ₩62.75b |
| Total assets | ₩91.60b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A058970's short term assets (₩27.5B) do not cover its short term liabilities (₩59.5B).
Long Term Liabilities: A058970's short term assets (₩27.5B) exceed its long term liabilities (₩3.2B).
Debt to Equity History and Analysis
Debt Level: A058970's net debt to equity ratio (13.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A058970's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A058970 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A058970 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 14.3% per year.